Antitumour necrosis factor α treatment reduces retinol-binding protein 4 serum levels in non-diabetic ankylosing spondylitis patients.

Fernanda Genre Raquel López-Mejías José A Miranda-Filloy Begoña Ubilla Beatriz Carnero-López Inés Gómez-Acebo Ricardo Blanco Rodrigo Ochoa Javier Rueda-Gotor Trinitario Pina Carlos González-Juanatey Javier Llorca Miguel A González-Gay

Ann Rheum Dis

Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IFIMAV, Santander, Spain.

Published: May 2014

Download full-text PDF	Source
http://dx.doi.org/10.1136/annrheumdis-2013-204484	DOI Listing

Publication Analysis

Top Keywords

antitumour necrosis

necrosis factor

factor treatment

treatment reduces

reduces retinol-binding

retinol-binding protein

protein serum

serum levels

levels non-diabetic

non-diabetic ankylosing

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!